Pfizer Inc.

Overview

Pfizer Inc. is a leading pharmaceutical company dedicated to discovering, developing, and delivering innovative medicines to improve patients' lives. Arena Pharmaceuticals, Inc., now a subsidiary of Pfizer, focuses on developing unique therapies for treating immune-inflammatory diseases.

Therapeutic areas

Active pharmaceutical ingredients supplied

Substances Pfizer Inc. is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

Pfizer Inc. holds 4 active (72 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ACTIVATED CALICHEAMICIN DERIVATIVEActive2015-12-11
• PRASTERONE ACETATEActive2014-12-11
• ALPHAMETHYL EPOXIDEActive1996-09-11
• HEPARIN SODIUM USPActive1976-08-03
• CABERGOLINE USPInactive2014-12-12
• LIPITOR (ATORVASTATIN CALCIUM) 10MG, 20MG, 40MG, 80MG ORALTABLETSInactive2009-01-29
• FLUMETHASONEInactive2001-08-01
• ERYTHROMYCINInactive1998-09-01
• OXYTETRACYCLINEInactive1998-09-01
• CEFOPERAZONE SODIUMInactive1998-09-01
• ERYTHROMYCIN STEARATEInactive1998-09-01
• STREPTOMYCIN SULFATEInactive1998-09-01
• TETRACYCLINE HYDROCHLORIDEInactive1998-09-01
• VIOMYCIN SULFATEInactive1998-09-01
• CARBENICILLIN INDANYL SODIUMInactive1998-09-01

Showing 15 of 72 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Pfizer Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.